Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AT-101: Preliminary Phase I/II data

Preliminary data from an ongoing, open-label Phase I/II trial in 34 evaluable patients showed that AT-101 in combination with docetaxel

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE